Home Frontmatter
Article Publicly Available

Frontmatter

Published/Copyright: November 6, 2020

Published Online: 2020-11-06
Published in Print: 2020-11-26

©2020 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Editorial and Executive Summary: IFCC Interim Guidelines on Clinical Laboratory testing during the COVID-19 Pandemic
  4. Mini Review
  5. Interferences in the measurement of circulating phosphate: a literature review
  6. Opinion Papers
  7. Lactate dehydrogenase: an old enzyme reborn as a COVID-19 marker (and not only)
  8. Procalcitonin (PCT)-guided antibiotic stewardship in Asia-Pacific countries: adaptation based on an expert consensus meeting
  9. Guidelines and Recommendations
  10. IFCC Interim Guidelines on Molecular Testing of SARS-CoV-2 Infection
  11. IFCC Interim Guidelines on Serological Testing of Antibodies against SARS-CoV-2
  12. IFCC Interim Guidelines on Biochemical/Hematological Monitoring of COVID-19 Patients
  13. Genetics and Molecular Diagnostics
  14. Genotype/phenotype relationship in Gaucher disease patients. Novel mutation in glucocerebrosidase gene
  15. Programme for Harmonization to the International Scale in Latin America for BCR-ABL1 quantification in CML patients: findings and recommendations
  16. General Clinical Chemistry and Laboratory Medicine
  17. Biotin interference: evaluation of a new generation of electrochemiluminescent immunoassays for high-sensitive troponin T and thyroid-stimulating hormone testing
  18. Validation of a liquid chromatography tandem mass spectrometry method for the simultaneous determination of hydroxychloroquine and metabolites in human whole blood
  19. The combined use of enzyme activity and metabolite assays as a strategy for newborn screening of mucopolysaccharidosis type I
  20. Reference Values and Biological Variations
  21. Faecal haemoglobin distributions by sex, age, deprivation and geographical region: consequences for colorectal cancer screening strategies
  22. Hematology and Coagulation
  23. Glycophorin A-based exclusion of red blood cells for flow cytometric analysis of platelet glycoprotein expression in citrated whole blood
  24. Assignment of international normalized ratio to frozen and freeze-dried pooled plasmas
  25. Cardiovascular Diseases
  26. Stabilization patterns and variability of hs-CRP, NT-proBNP and ST2 during 1 year after acute coronary syndrome admission: results of the BIOMArCS study
  27. Infectious Diseases
  28. SARS-CoV-2 serosurvey in health care workers of the Veneto Region
  29. Evaluation of three fully-automated SARS-CoV-2 antibody assays
  30. Results of the first pilot external quality assessment (EQA) scheme for anti-SARS-CoV2-antibody testing
  31. Frequency of serological non-responders and false-negative RT-PCR results in SARS-CoV-2 testing: a population-based study
  32. A biological profile for diagnosis and outcome of COVID-19 patients
  33. Letters to the Editors
  34. Can routine laboratory variables predict survival in COVID-19? An artificial neural network-based approach
  35. SARS-CoV-2 antibody performances: we need better criteria
  36. Upper respiratory samples pooling for screening SARS-CoV-2 infection: ready for the prime time?
  37. Validation of the Corona-Score for rapid identification of SARS-CoV-2 infections in patients seeking emergency department care in the United States
  38. “Stay home stay safe?” Systemic inflammation in subjects undergoing routine hematology tests during the lockdown period of COVID-19
  39. Congress Abstracts
  40. 52th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology (SIBioC – Laboratory Medicine)
Downloaded on 23.9.2025 from https://www.degruyterbrill.com/document/doi/10.1515/cclm-2020-frontmatter12/html
Scroll to top button